Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Gains from Investment Securities (2021 - 2025)

Historic Gains from Investment Securities for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $18000.0.

  • Krystal Biotech's Gains from Investment Securities fell 9921.43% to $18000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 13277.22%. This contributed to the annual value of $6.1 million for FY2024, which is 1918.7% up from last year.
  • Krystal Biotech's Gains from Investment Securities amounted to $18000.0 in Q3 2025, which was down 9921.43% from $12.1 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Gains from Investment Securities ranged from a high of $12.1 million in Q2 2025 and a low of $18000.0 during Q3 2025
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.4 million (2021), whereas its average is $1.9 million.
  • As far as peak fluctuations go, Krystal Biotech's Gains from Investment Securities surged by 82345.68% in 2023, and later tumbled by 9921.43% in 2025.
  • Over the past 5 years, Krystal Biotech's Gains from Investment Securities (Quarter) stood at $336000.0 in 2021, then crashed by 51.79% to $162000.0 in 2022, then skyrocketed by 644.44% to $1.2 million in 2023, then dropped by 23.8% to $919000.0 in 2024, then tumbled by 98.04% to $18000.0 in 2025.
  • Its last three reported values are $18000.0 in Q3 2025, $12.1 million for Q2 2025, and $1.8 million during Q1 2025.